“The present situation has exposed some structural weaknesses within the EU’s medicines provide chain in addition to a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She suggested that offer chain problems be tackled within an EU pharmaceutical technique predicted to get released by th